Dr. Mark C. Fisher, MD, MPH

Dr. Fisher practices at Prima Care in Fall River, Massachusetts.

Dr. Fisher's NPI, 1932308244, was assigned on July 16, 2007. Dr. Fisher graduated from Rutgers Robert Wood Johnson Medical School in 2002. Dr. Fisher's Massachusetts license number on file is 239044.

Dr. Fisher's primary practice is Prima Care, at 289 Pleasant St, Fall River, MA 02721 in Bristol County. The practice phone is (508) 676-3292.

Dr. Fisher's primary practice is Prima Care in Fall River, Massachusetts. Dr. Fisher is also affiliated with Charlton Memorial Hospital. The medical group on file is Prima Care. Dmand AI also links Dr. Fisher to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fisher practices, 4 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Fisher's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Fisher is board certified in rheumatology by the American Board of Internal Medicine. Dmand AI has Dr. Fisher's licenses on file in 5 states: Massachusetts, Florida, Rhode Island, New York and Pennsylvania.

Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, fluid in a joint, gout, joint arthropathy, joint pain and lupus among the conditions Dr. Fisher treats.

CMS data shows 26,953 Medicare services from Dr. Fisher across 38 procedure codes in 2024, for 1,451 Medicare patients. Medicare paid $596,541 for them. Every service was in an office.

CMS counts 1,451 Medicare patients who saw Dr. Fisher in 2024. The largest group is 65 to 74, with 597 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 33% are also on Medicaid. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fisher's median patient age at 61, with 76% women.

In 2024, Dr. Fisher wrote 7,004 Medicare Part D claims for 905 patients. 91% of them were for generic drugs. CMS names the drug for 6,692 of them, across 64 drugs with 11 or more claims each, at $2,974,238 in total drug cost. In 2023, CMS named 5,829 claims across 58 drugs.

Dr. Fisher accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fisher as offering telehealth.

Dmand AI links 47 papers to Dr. Fisher, published from 2009 to 2024. 2017 was the busiest year, with 4. The most frequent topics are Arthritis, Rheumatoid, Azaperone and Gout. Dr. Fisher has published most often in J Wildl Dis. Dr. Fisher's most frequent co-authors are Joel M. Kremer, MD, Mark Fisher, MD and Daria Barrett Crittenden, MD.

Dmand AI links Dr. Fisher to 2 clinical trials. Conditions studied include Arthritis, Rheumatoid, Lupus Erythematosus, Systemic and Connective Tissue Diseases. Open Payments lists research payments to Dr. Fisher that name 3 trials.

CMS Open Payments shows 26 general payments to Dr. Fisher from 8 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 67% of the total. UCB, Inc. paid the most, $1,920. It also lists 3 research payments totaling $4,946 from 2020 to 2024, naming 3 clinical trials.

Dr. Fisher graduated from Rutgers Robert Wood Johnson Medical School in 2002. Dr. Fisher is a member of ACP.

Dr. Fisher is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.